e Value of P wave dispersion in predicting reperfusion and infarct related artery patency in acute anterior myocardial infarction
A number of large clinical studies have demonstrated that achieving optimal coronary ow following thrombolysis in myocardial infarction (TIMI) reduces mortality, preserves le ventricular function and improves survival following acute myocardial infarction (MI) [1] [2] [3] [4] . In addition, it is known that the prognosis of patients with persistent occlusion of the infarct related artery (IRA), despite lytic therapy, is poor compared with that of patients with recanalized coronary arteries [5] [6] [7] . erefore, early detection of successful reperfusion and IRA patency in patients who received brinolytic therapy is of great importance in terms of prognosis and identi cation of candidates for rescue percutaneous coronary intervention (PCI) [8] [9] . For this purpose, relief of chest pain, early peak of cardiac biomarkers, appearance of reperfusion arrhythmia and various electrocardiographic (ECG) changes are used as noninvasive biomarkers, among which ST segment resolution at 90 minutes is one of the most important markers of successful reperfusion and prognosis [10] [11] [12] [13] . ST segment resolution is not always satisfactory to predict IRA patency and half of the patients without ST segment resolution have a patent IRA [14] [15] .
P wave dispersion (PWD) is de ned as the di erence between the maximum (Pmax) and minimum (P min ) P wave duration on standard 12-lead ECG. PWD is a measurement of the heterogeneity of atrial refractoriness [16] . Prolongation of PWD is known to be an independent risk factor for atrial brillation (AF) and shows intra-atrial and inter-atrial nonuniform conduction [16] [17] [18] .
e aim of this study was to investigate the value of PWD, measured via a 12-lead surface ECG, for predicting reperfusion and IRA patency in patients with acute anterior MI who were receiving thrombolytic therapy.
Methods
One hundred and three patients who were admitted to our hospital within the rst six hours a er acute anterior myocardial infarction and who received thrombolytic therapy were enrolled in this study. MI criteria were de ned as follows: (1) chest pain lasting >30 minutes and admission to the coronary care unit <24 hours from the onset of chest pain, (2) STsegment elevation ≥2 mm in at least two anterior electrocardiographic leads and (3) transient elevation of myocardial necrosis markers. Exclusion criteria included the presence of AF or utter either before or a er the assigned treatment, bundle branch block or any other intraventricular conduction abnormalities requiring permanent pace-maker insertion, preexcitation on admission or at the 24th hour ECG, cardiogenic shock, presence of either hypertrophic or dilated cardiomyopathy, abnormal thyroid functions, previously known congestive heart failure, congenital cardiac abnormalities, requirement for rescue angioplasty/stenting, severe valvular heart disease, previous beta blocker and other anti-arrhythmic drug usage and presence of unmeasurable P waves in more than four leads on any ECG. irty ve patients who did not meet these criteria were excluded from the study and 68 patients (55 males, 13 females; mean age 54±11.1) who met the criteria were divided into groups according to the presence of ST segment resolution on ECG and IRA patency. A signed informed consent form was obtained from each patient. e study was approved by the local ethics committee.
Treatment Protocol
Each patient was given tissue plasminogen activator-Alteplase (t-pA, Actlyse; Boeringer Ingelheim, Germany) as thrombolytic therapy. A dose of 15 mg intravenous bolus of Alteplase, followed by 0.75 mg/kg over 30 minutes (not to exceed 50 mg) and then 0.5 mg/kg over 60 minutes (not to exceed 35 mg), with a total dose not exceeding 100 mg, was administered. All patients also received 100-325 mg acetylsalicylic acid, low-ow nasal oxygen and a bolus of 60U/kg heparin followed by infusion of 12U/kg heparin, for 24-48 hours. Intravenous nitroglycerin and oral metoprolol (50-100 mg) were administered to the patients with normal heart rate and blood pressure values. Clopidogrel was given at a dose of 300 mg to patients aged ≤ 75 years and at a dose of 75 mg to those aged ≥ 75 years followed by 75 mg/day. None of the patients received antiarrhythmic drugs or calcium channel blockers. Reperfusion criteria were de ned as follows: a complete relief of chest pain, development of reperfusion arrhythmia and ≥70% ST segment resolution on ECG a er thrombolytic therapy. Coronary angiography was performed the next day for patients in whom reperfusion was achieved. Patients who had <70% ST segment resolution at 120 minutes and ongoing chest pain underwent immediate coronary angiography. A 12-lead electrocardiogram (ECG) was performed at 0 and 30, 60, 90 and 120 minutes a er the start of brinolytic therapy.
Echocardiography was performed to all patients within 48 hours. Two-dimensional echocardiographic measurements were performed according to standards outlined by the American Society of Echocardiography [19] . LA size was measured at end-systole in M-mode when ultrasound beam is perpendicular
Electrocardiographic measurements
All standard 12-lead ECGs were obtained using a recorder (Agilent, Andover, MA, USA) set at a 50 mm/s paper speed and 20 mm/mV standardization. All measurements of P-wave duration were calculated blindly by two observers. P waves on all derivations were measured on 12-lead surface ECG. e onset of the P wave was de ned as the point of rst visible upward slope from baseline for positive waveforms and as the point of rst downward slope from baseline for negative waveforms. e return to the baseline was considered as the end of the P wave. e Pmax measured in any of the 12 leads of the surface ECG was used as the longest atrial conduction time and P min measured in any of the 12 leads of the surface ECG was used as the shortest atrial conduction time. e mean Pwave duration for at least three complexes was calculated for each lead. P wave measurement could not be performed in each case because of low amplitude P waves in one or two of 12 leads in the ECG. Biphasic P waves were measured to the time of nal return to baseline. ST-segment deviation was measured with a handheld caliper and magnifying glass at 80 milliseconds a er the J-point in all available leads. e TP-segment was considered the preferred iso-electric baseline and STsegment deviation was measured to the nearest 0.05 mV. ST segment resolution was calculated and expressed as a percentage with this formula: (baseline ST elevation-90 minute ST elevation)/baseline ST elevation. Intra-and inter-observer variability were obtained from random 40 ECG recordings. Intra-and inter-observer variability for PWD were 3.2% and 3.5%, respectively.
Coronary angiography
All patients underwent coronary angiography on multiple projections using the Judkins' technique [21] . Cineangiography was performed by hand injection through diagnostic 6 Fr Judkins' catheters. Iopromide contrast (Ultravist-370; Schering AG, Berlin, Germany) was used in all patients. Angiographic procedure was performed using a computer based automated coronary analysis system (DCI-S; Philips Medical Imaging Systems, Eindhoven, Netherlands). Anterograde perfusion of the infarct-related artery was graded according to the classi cation system of the thrombolysis in myocardial infarction (TIMI) trial (grade 0 = no anterograde perfusion, grade 1 = minimal perfusion, grade 2 = partial perfusion and grade 3 = complete perfusion) [22] . IRA was considered as patent if TIMI ow grade was 2 or 3 and as occluded if TIMI ow grade was 0 and 1.
Statistical Analysis
All statistical analyses were carried out using SPSS statistical so ware (version 11.0, SPSS, Chicago, Illinois, USA). Data are presented as mean ± SD. Statistical comparison of quantitative data was performed by independent sample t-test. Categorical variables were summarized as percentages and were compared with the Chi-square test and Mann Whitney U test where appropriate. A multivariate logistic regression model was used to assess whether PWD measured at 0, 30, 60, 90 and 120 minutes was predictor of IRA patency and ST-segment resolution on ECG. A p value of <0.05 was considered statistically signicant. Table 1 shows clinical and demographic characteristics of the patients.
Results
ST-segment resolution occurred on ECG in 38 (55.8%) patients of the study group, whereas 30 (44.2%) patients had no ST-segment resolution on ECG. Following coronary angiography, the IRA was found to be patent in 31 (45.5%) patients but occluded in 37 (54.5%) patients. It was found that Table 1 shows the rate of coronary artery involvement. It was also found that chest pain in the patients with ST-segment resolution on ECG was relieved a er thrombolytic therapy. Nine patients developed atrial brillation during their hospital stay. Rescue PCI was performed in patients who failed to show signs of reperfusion. When the patients were divided into groups according to the presence of ST-segment resolution on ECG, PWD measured at 120 minutes was found to be signi cantly lower in patients with ST-segment resolution on ECG compared with that found in patients without ST-segment resolution on ECG (Table 2 ). In comparison, there were no signi cant di erences in PWD measured at 0, 30, 60 and 90 minutes between patients with and without ST-segment resolution. When the patients were grouped according to IRA patency, PWD measured at 120 minutes was signi cantly lower in patients with patent IRA compared with those with occluded IRA (Table 3 ). In comparison, there were no signi cant di erences in PWD measured at 0, 30, 60 and 90 minutes between both groups. Multivariate regression analysis revealed that PWD120 could predict IRA patency and ST-segment resolution on ECG (OR:0.907, CI:0.856 to 0.960; p=0.001; OR: 0.942, CI: 0,896 to 0,991; p=0.02, respectively).
On the basis of ROC curve analysis; a 51.6 ms or higher PWD120 was found to predict an occluded IRA with a 87% sensitivity (95% CI, 70.1-96.3; p<0.001, area under cuver 0.79). A 51 ms and higher PWD 120 was found to predict no reperfusion on ECG with a 74% sensitivity (95% CI, 56.9-86.6; p=0.003, area under curve 0.71) (Figure 1 ). e sensitivity and speci ty of ECG resolution in predicting IRA patency were 73% and 90%, respectively. e sensitivity and speci ty of PWD120 in predicting IRA patency were near the ECG resolution as 65% and 87% respectively. When both IRA patency and ECG resolution in predicting IRA patency were combined, the sensitivity and speci city were 89% and 85%, respectively. 
Discussion
Patients in whom successful reperfusion and IRA patency was achieved with thrombolytic therapy were found to present lower PWD values compared with pretreatment values. Additionally, a decrease in PWD, measured at 120 minutes a er the start of thrombolytic therapy, may serve is an e ective predictor for ST-segment resolution on ECG and IRA patency with coronary angiography. e goal of thrombolysis is to restore normal myocardial perfusion (TIMI 3 ow to the IRA with associated full tissue perfusion) within 60 to 90 minutes. TIMI 3 ow in the IRA a er thrombolysis has been associated with decreased mortality as well as decreased incidence of congestive cardiac failure, recurrent ischemia and improved le ventricular ejection fraction [23] . Prognosis a er ST elevation MI has been shown to relate directly to the delay between onset of symptoms and reperfusion therapy [1] and nal infarct size [24] .
It has been reported that reperfusion fails to occur at all in 25% of patients [25] [26] [27] and in 50-70% of patients at 90 minutes a er thrombolytic administration [25, 28] . Even though ST segment resolution is considered as the hallmark for successful reperfusion and prognosis, false negative ST segment resolution may occur in patients with patent IRA, who have normal epicardial ow but microvascular dysfunction and obstruction [29] . Noninvasive electrocardiographic markers such as reperfusion arrhythmias, single lead ST-segment recovery, and continuous segment monitorization contribute to determination of IRA patency and reperfusion [30] .
e occurrence rate of atrial brillation during acute MI ranges between 10% and 20% and develops for many reasons including le ventricle dysfunction with hemodynamic impairment [31] [32] [33] [34] [35] , atrial ischemia or infarction, right ventricular infarction, acute hypoxia, hypokalemia [35] [36] [37] . In a study including 2,475 patients admitted to the hospital with AMI, it was found that AF during AMI occurred in 297 patients (12%) [38] . In our study, AF developed in 9 of 60 patients (8.3%) during their hospital stay. Several studies have investigated the e ects of primary PCI on PWD in AMI patients. In one of these studies, Celik et al. demonstrated that PWD on 12-lead surface ECG measured before and a er PCI was signi cantly lower a er PCI than pre-intervention values in 125 patients undergoing primary PCI. When the patients were grouped according to TIMI perfusion grade (TMPG), a signi cant decrease was found in patients with TMPG 3 [39] . In another study, Akdemir et al. compared the e ects of brinoylitic therapy versus PCI on PWD in patients with acute anterior myocardial infarction who received successful reperfusion therapy [31] . In the mentioned study, there was a signi cant decrease in PWD in patients treated with PCI whereas the decrease in patients treated with brinolytic therapy did not reach statistical signi cance. In this study, we found a signi cant decrease in PWD a er brinolytic therapy compared to pretreatment values in patients with signs of successful reperfusion, a nding which is consistent with that of Celik and Akdemir et al. No signi cant di erence was found between patients without ST segment resolution on ECG and those with occluded IRA. Unlike the results of these studies, our study demonstrated that PWD measured at 120 minutes a er the start of thrombolytic therapy could predict ST-segment resolution on ECG and IRA patency. is result indicates that, if supported by other ndings of reperfusion, it may serve as a new noninvasive parameter to predict reperfusion. In our study, we also found similar sensitivity and speci city values of PWD120 compared with ST segment resolution. e sensitivity of combination of both parameters was higher than parameters seperately in predicting IRA patency. ry, PWD, P wave disp persion, Biphasic P waves in lead V1 and V2 may suggest LA overload [40] . ese di erences in biphasic P waves may be an explanation for prolonged PWD in some situations.In our study, there was no di erence in biphasic P waves in V1 or V2 leads. Reperfusion of coronary ow is necessary to resuscitate the ischemic myocardium. It is known that predictors of atrial brillation a er acute myocardial infarction include decreased ejection fraction, age and KILLIP class [33] [34] . Additionally, Baykan et al. found that Pmax and PWD are also predictors of AF in acute anterior MI [41] . In our study, AF developed in nine patients in whom PWD measured at 120 minutes was above 51 ms during their hospital stay. Ejection fraction values were higher and le atrium diameters were lower in patients who had patent IRA than those with occluded IRA although did not reach statistically signi cant. In addition to these ndings, PWD was found to be lower and EF was improved a er thrombolytic therapy in patients with signs of successful reperfusion and patent IRA. A patent IRA and successful reperfusion should result in reversal of ischemia in a shorter period of time and restoration of coronary ow can be achieved by better preservation of ventricular function. In addition, increased PWD in patients with failed reperfusion a er brinolytic therapy might also be a result of both hemodynamic impairment and ongoing tissue ischemia, which causes inhomogeneous and discontinuous atrial conduction.
Study Limitations
e main limitation of the present study was the small number of patients included. Our study was restricted to the anterior localization, which also restricted the applicability of the results. Patients with other than anterior localization of the myocardial infarction were excluded from the study because sinus node artery and AV node artery arise from the right coronary artery. Dilaveris et al. concluded that the manual measurement of the P wave duration in standard 12-lead ECGs is feasible, and more stable and reliable when performed on a high resolution screen of a digital EGG system than with the more conventional methods involving paper printed EGGs [42] . P wave dispersion was measured on paper printed ECGs. Although the method used to calculate PWD is time consuming, it becomes easier with repetitive measurements. Although 90 minutes a er brinolytic therapy is standart time for rescue PCI in most centers, PWD was measured at 120 minutes in our study -an another potential limitation of our study.
In conclusion, PWD values, which were found to be lower compared with pretreatment values in patients who received brinolytic therapy, can be a marker of successful reperfusion and patent IRA. PWD values, in combination with other reperfusion parameters, can contribute to the identi cation of rescue PCI candidates.
